A summary of an old article in the Wall Street Journal (2012). I know Reditux has been widely available in India for some time, but I didn't know that Roche had their own version in the market. The drug is called Ikgdar and is made by Roche under the company name Emcure Pharmaceuticals Ltd. I found some prices online: It looks like they call it Ristova in Pakistan. Here is the brochure: http://www.roche.com.pk/content/dam/ROPEGRA/Ristova/Ristova-ra-cmi_new (1).pdf Looks like the price is 37,500 indian rupee, or $585/£376 for 10 mg x 1 mL x 50ml. It looks like the price in the USA is around $2840 for the same amount of Rituxan/Rituximab (wholesale). Could this be right? I know dr. Kogelnik charges around $6800 per infusion for the drug, whether it is 500mg/1g. They also charge $2000 for costs related to the infusion. And has anyone received treatment for ME with Rituximab in India? I am very skeptical about untested biosimilars, but this product comes straight from Roche.